YCBD - cbdMD Corp Company Cash on Hand

Brandmark of cbdMD, Inc. (YCBD)

Margin compression driven by weak patent protection and an oversupply of CBD products triggered a spike on the chart. Cash reserves are stabilizing, with the 0.00 mark recording this figure. This allows cbdMD, Inc. (YCBD) to invest in R&D and extract purity, although physical retail expansion is hindered by high logistics costs, making development through online channels a priority.

YCBD - cbdmd.com Company Liquid Assets over the range 07/04/2022 - 11/21/2026

Metric breakdowns and analytics for cbdMD (YCBD)

- stock quotes and analyst forecast:
Basic company analysis:cbdMD YCBD
Brand item of cbdmd.com

Investors are assessing the financial stability of cbdMD, Inc. (YCBD) through the availability of liquid assets. This metric measures the volume of cash and cash equivalents, determining the issuer's ability to cover obligations without incurring external debt. Analyzing the free cash balance helps distinguish default risks from capital stagnation. For cbdMD, Inc. (YCBD), this confirms transparent resource control while maintaining market share. A high balance guarantees security but may limit the pace of expansion.

Competitors of cbdMD, Inc. (YCBD)

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|PTHL (Pheton) - Company Cash Funds|Company Cash Funds Aptorum|Company Cash Reserve Lyra Therapeutics Inc. LYRA|Company Cash Volume IBO|TNFA (TNF Pharmaceuticals, Inc.) - Company Cash Balance|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance